retatrutide and heart rate rate: what the clinical data actually shows What dose of retatrutide does

The association between percentage BMI change and rs10305420 was replication significant, with directionality consistent with that observed in the 23andMe cohort ( P = 0.001

Some might be saying, isnt it already used for pediatric epilepsy

Unlike your body's natural GLP-1, which rises and falls with meals, these drugs maintain elevated GLP-1-like activity around the clock

doi: 10.1038/S41598-021-96418-0

The American Academy of Pediatrics updated its guidelines in 2023 to recommend offering medications to patients 12 years and older with obesity alongside lifestyle treatment [182]

Tirzepatide did not increase risks of adverse renal events, urinary tract infections, nephrolithiasis (kidney stones), acute kidney injury, or renal cancer compared to placebo, insulin, or other GLP-1 receptor agonists